Contributor Page
Ropes & Gray LLP
By Douglas Hallward-Driemeier, Gregory Levine, Kellie Coombs, Albert F. Cacozza, Jr., Emerson Siegle
On June 12, 2018, the U.S. Food and Drug Administration issued two key documents outlining the agency's current thinking regarding drug and device manufacturers' communication of information not contained in product labeling.
By Ama Adams, Brendan Hanifin, Emerson Siegle
No superlative could aptly describe the magnitude of U.S. sanctions developments through the first six months of 2018.
By Kat Saunders Gregor, Gabrielle G. Hirz, Christiana M. Lazo
On May 21, 2018, the IRS Large Business & International Division ("LB&I") announced its fourth set of compliance campaigns.
By Leslie Spencer, Marta Belcher
In this podcast, intellectual property litigation partner Leslie Spencer and associate Marta Belcher address such topics as:
By Ropes & Gray LLP's Securities & Enforcement Practice Group
Raymond Lucia was an investment adviser charged by the SEC under the anti-fraud provisions of the Investment Advisers Act for misleading investors.
By Ryan Rohlfsen
As global regulations proliferate and become more complex, so too do the challenges of maintaining a high-performing global ethics & compliance program.
By Scott A. McKeown
While most remember the Cuozzo appeal as challenging the Patent Trial & Appeal Board's (PTAB) claim construction practices ...
By Ropes & Gray LLP's Health Care Practice
In January 2017, the federal departments and agencies that follow the Federal Policy for the Protection of Human Subjects, typically referred to as the Common Rule ...
By Douglas Hallward-Driemeier, Scott A. McKeown
April 2018, the Supreme Court issued its opinion in SAS Institute. As a result, petitioners and patent owners needed to immediately grapple with significant practice changes.
By Edward Baer, Jesse T. Cuevas, Keith Higgins
On June 14, 2018, speaking at the Yahoo Finance All Markets Summit: Crypto event in San Francisco, William Hinman, Director of the SEC's Division of Corporation Finance, made news ...
By Mark Barnes, Michael DiMaio, David Peloquin
The European General Data Protection Regulation, which took effect on May 25, 2018, requires that all processing of personal data subject to the GDPR must have a legal basis under the GDPR's Article 6.
By Deborah Monson, Lisa H. Bebchick, David Nasse, Kathryn M. Roulett
The recent summary denial by the CME Group, Inc., the financial market company comprised of four exchanges, including CME, CBOT, NYMEX, and COMEX, of an asset manager's access to all CME Group markets, ...
By Ropes & Gray LLP's Labor & Employment Practice, Ropes & Gray LLP's Sexual Misconduct & Workplace Harassment
Laws on workplace sexual harassment are changing dramatically for New York State employers, with still further changes in store for employers operating in New York City.
By Ropes & Gray LLP's FDA Regulatory Practice, Ropes & Gray LLP's Government Enforcement/White Collar Crime Practice
The changes to the guidance documents are extensive, but generally provide additional flexibility for manufacturers to convey certain types of product information.
By Scott A. McKeown
As explained earlier this week in a study by my partner Filko Prugo, Orange & Purple Book patents fare no worse at the PTAB than in the courts.
Contributor's Topics